Mirum Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Foster City, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Mirum Pharmaceuticals, Inc. has filed 662 SEC EDGAR filings since 20 Nov 2018

SEC filing history

Showing 276-300 of 662 matching filings.

Per page
25
Current page
12
4

4 filing

Filing date
05 Feb 2024
Reporting date
02 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Feb 2024
Reporting date
31 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91075

SC 13G filing

Filing date
31 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Jan 2024
Reporting date
23 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Jan 2024
Reporting date
23 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Jan 2024
Reporting date
23 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Jan 2024
Reporting date
23 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Jan 2024
Reporting date
23 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Jan 2024
Reporting date
23 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Jan 2024
Reporting date
16 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
18 Jan 2024
Reporting date
16 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Jan 2024
Reporting date
08 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Jan 2024
Reporting date
08 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Jan 2024
Reporting date
08 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Jan 2024
Reporting date
08 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Jan 2024
Reporting date
06 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91075

NEW ENTERPRISE ASSOCIATES 16, L.P. / MIRUM PHARMACEUTICALS, INC. -- SCHEDULE 13D

Filing date
29 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Dec 2023
Reporting date
05 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Nov 2023
Reporting date
10 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Nov 2023
Reporting date
10 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Nov 2023
Reporting date
10 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Nov 2023
Reporting date
09 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .